DeepOncology AI utilizes deep learning techniques in the fields of radiology and oncology to facilitate clinical cancer research and diagnosis. The company addresses the critical need for automated analysis tools to screen for liver metastases using 3D imaging. The integration of oncology, artificial intelligence, and computer vision has led to technology for the visual detection of liver cancer, one of the deadliest cancer types. DeepOncology AI's DeepOn device offers prospects for precise tumor characterization and early diagnosis and treatment. DeepOncology's express goal is to act as a facilitator between imaging science and clinical research, integrating oncology, radiology, artificial intelligence, and computer vision in clinically significant imaging applications. Through professional, empirical research the company aims to aid in the fight against cancer, where the result of a day's work is wholly tangible and of direct benefit to people's lives.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2018
- Website
- www.deeponcology.ai
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of DeepOncology AI?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now